Latest News
- December 28, 2021
Columbia research seven years in the making highlights potential therapeutic target for neurodegenerative disease
- December 11, 2021
Various programs around the country connect neurologic patients and caregivers with the arts. One such example is Arts & Minds, an organization founded by Dr. James M. Noble
Topic
- October 18, 2021
Dr. Manly was elected to NAM for her pioneering work improving detection of cognitive impairment among racially, culturally, and socio-economically diverse adults
- August 30, 2021
Finding out exactly which type of dementia you or your loved one has may be scary, but it’s important to identify the condition as early as possible
Topic
- June 8, 2021
On Monday, the FDA approved a new drug for Alzheimer’s disease—the first in nearly two decades. Biogen’s aducanumab aims to slow the cognitive decline often associated with the disease.
